Data / Research funding / Stem Cell Research - Umbilical Cord Blood/ Placenta - Human
Stem Cell Research - Umbilical Cord Blood/ Placenta - Human: 52 NIH awards ($54.1M) to 40 organizations
52 NIH awards ($54.1M) in the NIH spending category Stem Cell Research - Umbilical Cord Blood/ Placenta - Human, to 40 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
Get awards on Stem Cell Research - Umbilical Cord Blood/ Placenta - HumanWatch Stem Cell Research - Umbilical Cord Blood/ Placenta - Human
- Topic
- NIH spending category
Awards
52 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Inherited T cell defects: Diagnosis, Mechanisms and Treatments | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $9,040,281 | September 8, 2020 | August 31, 2025 | MARSON, ALEXANDER | reporter.nih.gov |
| Molecular Circuits in the Hematopoietic Stem Cell Niche | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $6,422,507 | August 15, 2020 | May 31, 2025 | DALEY, GEORGE Q | reporter.nih.gov |
| Multimodal Analysis of Gestational Health and Placental Injury in Opioid-Affected Pregnancies | NIH | National Institute on Drug Abuse | 2023 | $3,092,159 | August 15, 2023 | July 30, 2026 | OUYANG, YINGSHI | reporter.nih.gov |
| Investigating the effectiveness of COVID-19 testing choices, community engagement, and culturally-embedded mHealth literacy delivery in a medically-underserved, community-based sample | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $2,906,922 | November 11, 2020 | July 31, 2023 | AL-HENDY, AYMAN | reporter.nih.gov |
| Transcriptional Control During Erythropoiesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,660,464 | September 16, 2013 | October 31, 2025 | RANISH, JEFFREY A | reporter.nih.gov |
| Treating Kidney Injury by Modulating Heat Shock Proteins Using Soundwaves Combined with Mesenchymal Stem Cells and Their Extracellular Vesicles | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,048,853 | August 30, 2021 | July 31, 2025 | THAKOR, AVNESH SINH | reporter.nih.gov |
| Engineered Neuroprotective Stem-Cell Exosomes for In Utero Spina Bifida Therapy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,972,069 | September 30, 2020 | August 31, 2025 | FARMER, DIANA LEE | reporter.nih.gov |
| Prenatal metal mixtures and neurodevelopment: Role of placental extracellular microRNAs | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $1,860,956 | June 1, 2019 | May 31, 2024 | WRIGHT, ROSALIND J | reporter.nih.gov |
| Hippo Signaling Effector and Placentation | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $1,816,512 | April 1, 2020 | March 31, 2026 | PAUL, SOUMEN | reporter.nih.gov |
| Regulation and function of hematopoietic stem cell niches | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,682,486 | March 1, 2000 | December 31, 2024 | GRITSMAN, KIRA | reporter.nih.gov |
| Role of VGLL1 in human placental development and trophoblast specification | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,539,133 | February 1, 2019 | January 31, 2025 | SONCIN, FRANCESCA | reporter.nih.gov |
| A novel approach for treating diabetes using pulsed focused ultrasound and intra-arterial delivery of mesenchymal stem cell based therapies directly into the pancreas | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,349,935 | September 1, 2019 | May 31, 2024 | THAKOR, AVNESH SINH | reporter.nih.gov |
| Efficient Sendai virus mediated CRISPR/Cas9 gene editing to protect hematopoietic stem cells from HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,241,707 | June 11, 2018 | May 31, 2024 | AN, DONG SUNG | reporter.nih.gov |
| Optimization of small molecule integrin activators to enhance cord blood transplant | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,094,056 | February 15, 2022 | January 31, 2025 | VANDERSLICE, PETER | reporter.nih.gov |
| Estrogen Receptor Signaling in Hematopoietic Stem Cell Proliferation and Mobilization | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,082,400 | August 20, 2020 | May 31, 2025 | OGURO, HIDEYUKI | reporter.nih.gov |
| Single-cell multi-omic analysis of opioid-mediated HIV disease pathogenesis | NIH | National Institute on Drug Abuse | 2023 to 2024 | $1,009,425 | September 30, 2023 | August 31, 2025 | COLLINS, KATHLEEN L. | reporter.nih.gov |
| Pericyte reprogramming in fibrosis | NIH | National Institute of Biomedical Imaging and Bioengineering | 2023 to 2024 | $970,522 | August 1, 2023 | July 31, 2025 | GONZALEZ, ANJELICA | reporter.nih.gov |
| A small molecule integrin activator to enhance cord blood transplant | NIH | National Heart, Lung, and Blood Institute | 2021 | $928,941 | September 1, 2016 | February 28, 2023 | VANDERSLICE, PETER | reporter.nih.gov |
| Novel humanized mouse model developed from cord blood CD34 positive HSC and autologous iPS cell derived thymus | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $782,684 | May 1, 2017 | April 30, 2022 | BREHM, MICHAEL ALLEN | reporter.nih.gov |
| Immune Compromised Zebrafish for Cell Transplantation | NIH | Office of the Director, National Institutes of Health | 2021 | $769,909 | August 1, 2013 | June 30, 2022 | LANGENAU, DAVID MICHAEL | reporter.nih.gov |
| Dissecting gene dysregulation at the maternal-fetal interface in preeclampsia | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $737,270 | July 1, 2018 | December 31, 2023 | FISHER, SUSAN J. | reporter.nih.gov |
| A Human Organoid Model of Polycystic Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $706,000 | September 15, 2018 | June 30, 2023 | FREEDMAN, BENJAMIN SOLOMON | reporter.nih.gov |
| Combined Molecular Excision Therapy (CMET) for Eliminating HIV-1 | NIH | National Institute of Mental Health | 2021 | $676,262 | September 20, 2017 | July 31, 2024 | GENDELMAN, HOWARD E | reporter.nih.gov |
| Epigenetic programming of infant mesenchymal stem cells: mechanisms for obesity and diabetes risk in humans | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $620,449 | July 25, 2018 | June 30, 2024 | BOYLE, KRISTEN ELIZABETH | reporter.nih.gov |
| Novel humanized mouse model of mucosal immunity | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $525,000 | January 1, 2023 | December 31, 2024 | PALUCKA, ANNA KAROLINA | reporter.nih.gov |
| The Role of Placental Maternal Vascular Underperfusion in Neonatal Pulmonary Hypertension | NIH | National Heart, Lung, and Blood Institute | 2022 | $517,030 | February 15, 2018 | January 31, 2024 | MESTAN, KAREN K | reporter.nih.gov |
| Selective Glucocorticoid Action in the Developing Brain | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $509,336 | March 1, 2017 | January 31, 2022 | DEFRANCO, DONALD B | reporter.nih.gov |
| The Role of Placental Maternal Vascular Underperfusion in Neonatal Pulmonary Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 | $484,884 | February 15, 2018 | September 30, 2021 | MESTAN, KAREN K | reporter.nih.gov |
| Integrating health informatics in a scalable stepped care self-management program for survivors after hematopoietic cell transplantation | NIH | National Cancer Institute | 2022 | $459,965 | May 1, 2017 | November 30, 2023 | BAKER, KEVIN S | reporter.nih.gov |
| Exploring the features of HIV exceptional elite controllers in humanized mice | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $437,798 | August 20, 2021 | July 31, 2024 | AKKINA, RAMESH | reporter.nih.gov |
| Enhancing CAR T Cell Homing Through Glycoengineering | NIH | National Cancer Institute | 2023 to 2024 | $407,075 | March 9, 2023 | February 28, 2026 | AL-ATRASH, GHEATH | reporter.nih.gov |
| Off-the-shelf engineered NK cells for the treatment of AML | NIH | National Cancer Institute | 2021 | $366,000 | December 20, 2016 | November 30, 2022 | REZVANI, KATY | reporter.nih.gov |
| High Fidelity Diffusion MRI for Children with Cerebral Palsy in Stem Cell Therapy | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $352,188 | February 15, 2012 | June 30, 2023 | SONG, ALLEN W | reporter.nih.gov |
| Improving The Reproducibility and Genetic Stability of IPSC and Differentiated Cells Through Oncogene-Free Reprogramming and Fully Human Growth Factors | NIH | National Institute of General Medical Sciences | 2021 | $346,021 | August 15, 2020 | August 14, 2022 | MOY, ALAN B | reporter.nih.gov |
| Stem cell-based biomaterials for spinal regeneration in neural tube defects | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $318,709 | September 1, 2017 | May 31, 2023 | KUNISAKI, SHAUN MICHAEL | reporter.nih.gov |
| Antibodies in the neurologic effects of COVID-19 | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $300,000 | September 6, 2024 | August 31, 2025 | AL-HARTHI, LENA | reporter.nih.gov |
| Manipulating the Stem Cell Epigenome to Improve Bone Marrow Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $283,500 | August 1, 2019 | May 31, 2022 | CHALLEN, GRANT ANTHONY | reporter.nih.gov |
| Mechanisms that Enhance and Suppress HIV-1 Resistance in Gene Edited Primary Human Cells | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $262,494 | August 12, 2023 | April 30, 2025 | DUDEK, AMANDA M | reporter.nih.gov |
| Investigating the role of epitranscriptomic A-to-I RNA editing in T-cell acute lymphoblastic leukemia | NIH | National Cancer Institute | 2021 | $191,213 | September 1, 2019 | February 28, 2023 | JIANG, QINGFEI | reporter.nih.gov |
| Enhancing the potency of mesenchymal stem cell therapies for kidney diseases using lab-on-a-particle technology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $185,208 | September 21, 2021 | January 20, 2023 | DI CARLO, DINO | reporter.nih.gov |
| Mesenchymal stem cell senescence in diabetic nephropathy (K23 COVID Admin Supplement) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $163,935 | May 19, 2020 | December 31, 2022 | HICKSON, LATONYA J | reporter.nih.gov |
| Investigating and targeting the translational landscape of DBA | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 | $150,000 | August 15, 2023 | July 31, 2024 | BARNA, MARIA | reporter.nih.gov |
| Investigating thrombocytopenia absent radius syndrome during primitive and definitive hematopoiesis using an induced pluripotent stem cell model | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $131,182 | September 1, 2022 | August 31, 2025 | NATIONS, CATRIANA | reporter.nih.gov |
| Transcriptional Control of HIV Latency in Hematopoietic Stem and Progenitor Cells | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $116,315 | September 1, 2021 | August 31, 2024 | VIRGILIO, MARIA | reporter.nih.gov |
| Developmental disruption in the transplacental transmission strategy of Toxoplasma gondii | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $104,687 | May 1, 2022 | April 30, 2025 | CABO, LEAH FRANCES | reporter.nih.gov |
| Deciphering the molecular mechanism of ineffective erythropoiesis in MDS-5q | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 | $99,999 | April 21, 2023 | March 31, 2025 | ABKOWITZ, JANIS L | reporter.nih.gov |
| Proteotranscriptomic regulation of homing and engraftment in hematopoietic stem and progenitor cells for hematopoietic cell transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $79,956 | September 30, 2021 | October 29, 2022 | ROPA, JAMES PATRICK | reporter.nih.gov |
| Effect of Pre- and Peri-Implantation Zika Virus Infection on Fetal Development | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $72,630 | September 1, 2019 | August 31, 2022 | LACKO, LAURETTA A. | reporter.nih.gov |
| Johns Hopkins Retinal Degenerations and Visual Electrophysiology Conference 2023. | NIH | National Eye Institute | 2023 | $70,000 | September 1, 2023 | August 31, 2024 | SINGH, MANDEEP | reporter.nih.gov |
| Novel Regulators of GPCR Signaling in Hematopoietic Stem Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $68,562 | September 16, 2019 | September 15, 2022 | NEVITT, CHRISTOPHER DAVID | reporter.nih.gov |
| Electrophysiological characterization of human pluripotent stem cell derived cardiomyocytes and their application as biological pacemakers | NIH | National Heart, Lung, and Blood Institute | 2021 | $40,175 | May 1, 2020 | February 28, 2022 | WOLFSON, DAVID | reporter.nih.gov |
| Investigating nephron-vascular crosstalk in tissue patterning and maturation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $6,856 | September 30, 2020 | October 4, 2021 | RYAN, ANNE REGINA | reporter.nih.gov |
Organizations
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2024 | 14 | $7,610,926 | 0 | $0 |
| 2023 | 24 | $14,323,032 | 0 | $0 |
| 2022 | 24 | $12,588,317 | 0 | $0 |
| 2021 | 37 | $19,540,345 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.